MannKind Corp (NASDAQ:MNKD)

4.55
Delayed Data
As of May 26
 -0.005 / -0.11%
Today’s Change
2.91
Today|||52-Week Range
5.73
-13.76%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$1.2B

Company Description

MannKind Corp. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic products and devices for those with endocrine and orphan lung diseases. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Contact Information

MannKind Corp.
1 Casper Street
Danbury Connecticut 06810
P:(818) 661-5000
Investor Relations:

Employees

Shareholders

Individual stakeholders5.09%
Other institutional28.75%
Mutual fund holders24.03%

Top Executives

Michael E. CastagnaChief Executive Officer & Director
Lauren M. SabellaChief Operating Officer & Executive Vice President
Steven B. BinderChief Financial Officer
Joseph KocinskyChief Technology Officer
Kevin KaisermanVice President-Medical Affairs & Safety